Kinga Nowicka is a Head of Process Development at King's College London Gene Therapy Vector Facility (GTVF). With over a decade of industrial experience, specializing in viral vector manufacturing process development. She uses that experience to develop scalable platforms to produce clinical and commercial grade products. Kinga leads on development on analytical methods used to identify, separate and quantify drug products intended for clinical and commercial manufacturing.